Barlerin

Cat. No.: OB0225WX-1624

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Barlerin is an iridoid glycoside that modulates the HMGB1-dependent NF-κB signaling pathway and inhibits intracellular Ca2+ elevation and caspase-3 activation to maintain blood-brain barrier integrity.

Synonym: 8-O-Acetylshanzhiside methyl ester; ND01; 57420-46-9; 8-O-Acetyl shanzhiside methyl ester; Methyl (1S,4aS,5R,7S,7aS)-7-acetyloxy-5-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate; 5beta-Dihydro Finasteride; Cyclopenta[c]pyran-4-carboxylic acid,7-(acetyloxy)-1-(b-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5-hydroxy-7-methyl-, methyl ester, (1S,4aS,5R,7S,7aS)-; MFCD15071141; 8-O-Acetylshanzhisidemethylester; (4aR,4bS,6aS,7S,9aS,9bS,11aS)-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide; (5ss,17ss)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrostane-17-carboxamide; [4aR-(4aa,4bss,6aa,7a,9ass,9ba,11aa)]-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide; Cyclopenta(c)pyran-4-carboxylic acid, 7-(acetyloxy)-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5-hydroxy-7-methyl-, methyl ester, (1S-(1alpha,4aalpha,5alpha,7alpha,7aalpha))-; Methyl (1S,4aS,5R,7S,7aS)-7-acetoxy-5-hydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate

CAS No.: 57420-46-9

Compound CID: 162823

Formula: C₁₉H₂₈O₁₂

Formula Weight: 448.42

Specification

Relative Density: 1.52 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Barlerin is employed in phytochemical studies to examine its potential anti-inflammatory and antioxidant activities within the context of traditional medicinal plant research.